Core Points - The company has received a medical device registration certificate for a new product, a disposable sterile temperature-sensing silicone catheter, from the Hainan Provincial Drug Administration [1][3] - The product is designed for use in medical departments for indwelling catheterization or drainage, and it can also measure bladder temperature [2][3] - The registration certificate is valid from September 11, 2025, to September 10, 2030 [3] Product Details - The registered product includes a dual-lumen and a triple-lumen design, consisting of components such as a one-way valve, catheter body, inflation chamber, balloon, temperature chamber, and temperature probe [1][2] - Over 20 domestic competitors have also obtained similar medical device registration certificates [3] Impact on the Company - The acquisition of the medical device registration certificate is expected to enhance the product variety of the subsidiary, Hainan Weili Medical Technology Development Co., Ltd., and improve the company's market competitiveness [4] - Currently, the product has not been sold, and the immediate impact on the company's financial performance is expected to be minimal [4]

（编辑 楚丽君） 证券日报网讯 9月12日晚间，维力医疗发布公告称，全资子公司海南维力医疗科技开发有限公司于近日 收到海南省药品监督管理局颁发的《中华人民共和国医疗器械注册证》，产品名称：一次性使用无菌测 温型硅胶导尿管。 ...

Group 1 - The core point of the article is that Weili Medical has received a medical device registration certificate for its product, a disposable sterile temperature-sensing silicone catheter, from the Hainan Provincial Drug Administration [1] - Weili Medical's revenue composition for the year 2024 is reported to be 98.04% from medical devices and 1.96% from other businesses [2] - As of the report, Weili Medical has a market capitalization of 4.2 billion yuan [3]

Core Viewpoint - Company Vigor Medical (603309.SH) has received a medical device registration certificate for its product, a disposable sterile temperature-sensing silicone catheter, from the Hainan Provincial Drug Administration, which is expected to enhance its product variety and market competitiveness [1] Group 1 - The subsidiary Hainan Vigor has obtained the medical device registration certificate, which is beneficial for diversifying its product offerings [1] - The registration is anticipated to positively impact the company's operational performance, although the product has not yet been sold [1] - The short-term effect on Hainan Vigor and the company's financial performance is expected to be minimal [1]

维力医疗9月12日公告，全资子公司海南维力医疗科技开发有限公司于近日收到海南省药品监督管理局 颁发的《中华人民共和国医疗器械注册证》，产品名称为一次性使用无菌测温型硅胶导尿管。该产品丰 富了子公司产品种类，有助于提高公司产品的市场竞争力，对公司经营将产生积极影响。但目前该产品 尚未进行销售，对公司经营业绩影响较小。 ...

此次子公司海南维力取得上述医疗器械注册证，有利于丰富子公司产品种类，有助于提高公司产品的市 场竞争力，对公司经营将产生积极影响。截至目前，海南维力上述产品尚未进行销售，上述医疗器械注 册证的取得，短期内对海南维力及公司的经营业绩影响较小。 维力医疗（603309）(603309.SH)发布公告，公司全资子公司海南维力医疗科技开发有限公司(简称"海南 维力")于近日收到海南省药品监督管理局颁发的《中华人民共和国医疗器械注册证》，产品名称：一次 性使用无菌测温型硅胶导尿管。 ...

Core Viewpoint - The announcement indicates that the wholly-owned subsidiary of Weili Medical, Hainan Weili Medical Technology Development Co., Ltd., has received a medical device registration certificate for a new product, which is expected to enhance the company's product offerings and market competitiveness [1] Group 1: Product Registration - Hainan Weili has obtained the registration certificate numbered Qiong Xie Zhu Zheng 20252140082 from the Hainan Provincial Drug Administration for a "disposable sterile temperature-measuring silicone catheter" [1] - The product consists of components such as a one-way valve, catheter body, inflation cavity, balloon, temperature cavity, and temperature probe, and is designed for use in medical settings for catheterization or drainage while measuring bladder temperature [1] - The registration certificate is valid until September 10, 2030, which provides a long-term opportunity for the company to market this product [1] Group 2: Market Impact - The acquisition of the registration certificate is expected to enrich the product variety of Hainan Weili and improve the company's market competitiveness [1] - However, the actual sales performance of the product post-launch will depend on future marketing efforts, indicating that the short-term impact on Hainan Weili and the company's overall performance may be limited [1]